| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.43 | 0.0004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.001 |